Pimavanserin is a urea derivative and an atypical antipsychotic active pharmaceutical ingredient. It functions as a 5-hydroxytryptamine 2A receptor inverse agonist and is used in pharmaceutical manufacturing for formulations targeting hallucinations and delusions associated with Parkinson's disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 706779-91-1
Pimavanserin tartrate
pharmaceutical raw material
3,5-Dimethyl-1-adamantanol
pharmaceutical raw material
Octenidine hydrochloride
pharmaceutical raw material
Cefpiramide
pharmaceutical raw material
Cloxacillin sodium monohydrate
pharmaceutical raw material
1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
RKEWSXXUOLRFBX-UHFFFAOYSA-N
CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C